Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-x(L)

Cell Growth and Differentiation

Volumn 8, Issue 10, 1997, Pages 1083-1089

  Chatterjee, Devasis ^a   Han, Zhiyong ^a   Mendoza, John ^b   Goodglick, Lee ^c   Hendrickson, Eric A ^a   Pantazis, Panayotis ^b   Wyche, James H ^a  

^a BROWN UNIVERSITY   (United States)

^b Stehlin Found for Cancer Research   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GRANULOCYTE; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; BCL-X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; DNA-BINDING PROTEINS; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; IMMEDIATE-EARLY PROTEINS; LEUKEMIA, MYELOID; MONOCYTES; PHORBOL 12,13-DIBUTYRATE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0030861641     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75: 2458-2462, 1978.
2. Breitman, T. R., Scolnick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
3. Dexter, D. L., Barbosa, J. A., and Calabresi, P. N. N-Dimethylformamide induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res., 39: 1020-1025, 1979.
4. Rovera, G., O'Brien, T. G., and Diamond, L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science (Washington DC), 204: 868-870, 1979.
5. Benito, A., Grillot, D., Nunez, G., and Luna-Fernandez, J. L. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am. J. Pathol., 146: 481-490, 1995.
6. Martin, S. J., Bradley, J. G., and Cotter, T. G. HL-60 cells induced to differentiate toward neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
7. Ryves, W. J., Dimitrijevic, S., Gordge, P. C., and Evans, F. J. HL-60 cell differentiation induced by phorbol- and 12-deoxyphorbol esters. Carcinogenesis (Lond.), 15: 2501-2506, 1994.
8. Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezella, F., Pierotti, M., and Della Porta, G. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood, 79: 1291-1296, 1992.
9. Lotem, J., and Sachs, L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ., 4: 41-47, 1993.
10. Campos, L., Rouault, J-P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J-P., and Guyotat, D. High expression of bcl-2 protein in acute myeloid leukemic cells is associated with poor response to chemotherapy. Blood, 81: 3091-3096, 1993.
11. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608, 1993.
12. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., and Craig, R. W. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA, 90: 3516-3520, 1993.
13. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irle, S., Millan, J. A., and Reed, J. C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80: 279-284, 1995.
14. Lin, E. Y., Orlofsky, A., Wang, H-G., Reed, J. C., and Prytowsky, M. B. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood, 87: 983-992, 1996.
15. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans, J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7350-7354, 1994.
16. Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., and Loh, D. Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-X-deficient mice. Science (Washington DC), 267: 1506-1510, 1995.
17. Oltvai, Z., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
18. L and Bcl-2, displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
19. Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., Lutz, R. J., and Chinnadurai, G. Bik, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene, 11: 1921-1928, 1995.
20. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 374: 733-736, 1995.
21. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D., and Barr, P. J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
22. Hockenberry, D. M. Bcl-2, a novel regulator of cell death. Bioessays, 17: 638-651, 1995.
23. L-Bak peptide complex: recognition between regulators of apoptosis. Science (Washington DC), 275: 983-986, 1997.
24. McCarthy, J. V., Fernandes, R. S., and Cotter, T. G. Increased resistance to apoptosis associated with HL-60 myeloid differentiation status. Anticancer Res., 14: 2063-2072, 1994.
25. 3 results in the differentiation toward neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia (Baltimore), 9: 410-418, 1995.
26. Grillot, D. A. M., Merino, R., Pena, J. C., Fanslow, W. C., Finkelman, F. D., Thompson, C. B., and Nunez, G. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med., 183: 381-396, 1996.
27. L in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol., 25: 1352-1355, 1995.
28. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med., 182: 1973-1983, 1995.
29. L. Nature (Lond.), 374: 811-813, 1995.
30. L) in human lymphomas. Br. J. Haematol., 92: 900-906, 1996.
31. L. Blood, 87: 3837-3843, 1996.
32. Sherr, C. J., Rettenmeier, C. W., Sacco, R., Roussel, M. F., Look, A. T., and Stanley, E. R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell, 41: 665-676, 1985.
33. Nguyen, H. Q., Hoffman-Liebermann, B., and Liebermann, D. A. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell, 72: 197-209, 1993.
34. Tortora, G., Clair, T., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide targeted against type II B regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc. Natl. Acad. Sci. USA, 87: 705-708, 1990.
35. Han, Z., Chatterjee, D., and Wyche, J. H. Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-cl-cAMP. J. Pharmacol. Exp. Ther., 265: 790-794, 1993.
36. Munn, D. H., Beall, A. C., Song, D., Wrenn, R. W., and Throckmorton, D. C. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon-γ. J. Exp. Med., 181: 127-136, 1995.
37. Ishizaki, Y., Cheng, L., Mudge, A. W., and Raff, M. C. Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol. Biol. Cell, 6: 1443-1458, 1995.
38. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
39. Naumovski, L., and Cleary, M. L. Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood, 83: 2261-2267, 1994.
40. Park, J. R., Robertson, K., Hickstein, D. D., Tsai, S., Hockenberry, D. M., and Collins, S. J. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood, 84: 440-445, 1994.
41. Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J. C., and Pierotti, M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood, 85: 359-367, 1995.
42. L. Cancer Res., 56: 1621-1628, 1996.
43. Park, J. R., Bernstein, I. D., and Hockenberry, D. M. Primitive hematopoietic precursors express Bcl-x but not Bcl-2. Blood, 86: 868-876, 1995.
44. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med., 182: 821-828, 1995.
45. 2 checkpoint in p53-independent apoptosis induction by x-irradiation. Mol. Cell. Biol., 15: 5849-5857, 1995.
46. Mangan, D. F., Welch, D. R., and Wahl, S. M. Lipopolysaccharide, tumor necrosis factor α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol., 146: 1541-1546, 1991.
47. Mangan, D. F., and Wahl, S. M. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol., 147: 3408-3412, 1991.
48. Nathan, C. W., Murray, H. W., and Cohn, Z. A. Current concepts: the macrophage as an effector cell. N. Engl. J. Med., 303: 622-626, 1980.
49. Goodglick, L. A., and Kane, A. B. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res., 46: 5558-5566, 1986.
50. Chen, M., Quintans, J., Fuks, Z., Thompson, C. B., Kufe, D. W., and Weichselbaum, R. R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor, and ceramide. Cancer Res., 55: 991-994, 1995.
51. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Holtz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells by flow cytometry. Cytometry, 13: 795-808, 1992.
52. Afanasyev, V. N., Korol, B. A., Matylevich, N. P., Pechatnikov, V. A., and Umansky, S. R. The use of flow cytometry for the investigation of cell death. Cytometry, 14: 603-609, 1993.
53. Telford, W. G., King, L. E., and Fraker, P. J. Rapid quantitation of apoptosis in pure and heterogenous cell populations using flow cytometry. J. Immunol. Methods, 172: 1-16, 1994.
54. Frankfurt, O. S., Byrnes, J. J., Seckinger, D., and Sugarbaker, D. E. V. Apoptosis (programmed cell death) and the evaluation of chemosensitivity in chronic lymphocytic leukemia and lymphoma. Oncol. Res., 5: 37-42, 1993.
55. Schrier, S. L. Internucleosomal cleavage of DNA is insufficient evidence to conclude that cell death is apoptotic. Blood, 83: 2005-2006, 1994.
56. Breitman, T. R. Growth and differentiation of human myeloid leukemia cell line HL-60. Methods Enzymol., 190: 118-130, 1990.